Catalyst Pharmaceuticals (CPRX)
(Delayed Data from NSDQ)
$15.94 USD
+0.29 (1.85%)
Updated May 10, 2024 04:00 PM ET
After-Market: $16.05 +0.11 (0.69%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth D Momentum A VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 37% (94 out of 251)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.52 | 9.99 |
Current Quarter Estimate | 0.45 | -2.04 | 57.00 |
Year Ago Quarter Estimate | 0.33 | -0.59 | 52.54 |
Next Quarter Estimate | 0.53 | -2.00 | 61.00 |
Next Year Estimate | 2.33 | 6.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -2.55 | 11.80 | 15.67 |
Next Year | 21.99 | 15.40 | 9.31 |
Last 5 Years | NA | 4.90 | 8.10 |
Next 5 Years | 10.00 | 22.20 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 15.94 | -5.88 |
Price/Book (MRQ) | 3.35 | 1.91 |
Price/Cash Flow (MRFY) | 7.75 | 9.59 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 15.83% | 0.82% |
Return on Equity (TTM) | 25.08% | -24.69% |
Debt to Equity (MRQ) | 0.00 | 0.04 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.